{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T17:13:40Z","timestamp":1769793220344,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Frankel Cardiovascular Center","award":["MI-AORTA Research Grant"],"award-info":[{"award-number":["MI-AORTA Research Grant"]}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL176683"],"award-info":[{"award-number":["HL176683"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL141891"],"award-info":[{"award-number":["HL141891"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Calcific aortic valve disease (CAVD) is a progressive and life-threatening condition characterized by fibrocalcific remodeling of the valve leaflets. Valvular interstitial cells (VICs) are central mediators of calcific aortic valve disease (CAVD), as their osteogenic trans-differentiation drives pathological matrix remodeling and calcium deposition within the valve leaflets. Human-induced pluripotent stem cell-derived valvular interstitial cells (hiVICs) represent a promising patient-specific platform for disease modeling. While primary VICs (pVICs) readily undergo mineralization under osteogenic stimulation, hiVICs fail to calcify in conventional two-dimensional (2D) cultures. Our data suggests that the inability of hiVICs to calcify in 2D culture is related to FOXO1 (Forkhead box protein O1) activity, which suppresses the osteogenic transcriptional program by inhibiting RUNX2 (Runt-related transcription factor 2). To address this limitation, we then developed a three-dimensional tissue ring construct using hiVICs. When cultured in osteogenic medium, these constructs exhibited robust calcification, as confirmed by Alizarin Red and Von Kossa staining. FOXO1 was also identified as a mediator of calcification in the tissue ring constructs. Metformin treatment restored\n                    <jats:italic>FOXO1<\/jats:italic>\n                    expression and inhibited calcification, while AS1842856, a selective FOXO1 inhibitor, exacerbated tissue construct mineralization and led to a near-complete tissue collapse. In summary, we establish a functional 3D hiVIC-based model of CAVD enabling mechanistic investigation and pharmacological screening and identify FOXO1 as a critical regulator of osteogenic transition.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s12015-025-11030-3","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:06:17Z","timestamp":1764842777000},"page":"963-975","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Construction of a Three-Dimensional Calcific Aortic Valve Disease Model Using Human iPSC-Derived Valvular Interstitial Cells"],"prefix":"10.1007","volume":"22","author":[{"given":"Ruikang","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dogukan","family":"Mizrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"28","key":"11030_CR1","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1093\/eurheartj\/ehx219","volume":"38","author":"P Mathieu","year":"2017","unstructured":"Mathieu, P., & Arsenault, B. J. (2017). CAVD: Civilization aortic valve disease. European Heart Journal, 38(28), 2198\u20132200. https:\/\/doi.org\/10.1093\/eurheartj\/ehx219","journal-title":"European Heart Journal"},{"key":"11030_CR2","doi-asserted-by":"publisher","unstructured":"Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., O\u2019Gara, P. T., Rigolin, V. H., Sundt, T. M., Thompson, A., & Toly, C. (2021). 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: A report of the American college of Cardiology\/American heart association joint committee on clinical practice guidelines. Journal of the American College of Cardiology, 77(4). https:\/\/doi.org\/10.1016\/j.jacc.2020.11.018","DOI":"10.1016\/j.jacc.2020.11.018"},{"key":"11030_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezad057","author":"B Kramer","year":"2023","unstructured":"Kramer, B., Vekstein, A. M., Bishop, P. D., Lowry, A., Johnston, D. R., Kapadia, S., Krishnaswamy, A., Blackstone, E. H., & Roselli, E. E. (2023). Choosing transcatheter aortic valve replacement in porcelain aorta: Outcomes versus surgical replacement. European Journal of Cardio-Thoracic Surgery\u202f: Official Journal of the European Association for Cardio-Thoracic Surgery. https:\/\/doi.org\/10.1093\/ejcts\/ezad057","journal-title":"European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery"},{"issue":"30","key":"11030_CR4","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1093\/eurheartj\/ehab375","volume":"42","author":"TH J\u00f8rgensen","year":"2021","unstructured":"J\u00f8rgensen, T. H., Thyregod, H. G. H., Ihlemann, N., Nissen, H., Petursson, P., Kjeldsen, B. J., Steinbr\u00fcchel, D. A., Olsen, P. S., & S\u00f8ndergaard, L. (2021). Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. European Heart Journal, 42(30), 2912\u20132919. https:\/\/doi.org\/10.1093\/eurheartj\/ehab375","journal-title":"European Heart Journal"},{"issue":"8","key":"11030_CR5","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41569-023-00845-7","volume":"20","author":"LHM Moncla","year":"2023","unstructured":"Moncla, L. H. M., Briend, M., Boss\u00e9, Y., & Mathieu, P. (2023). Calcific aortic valve disease: Mechanisms, prevention and treatment. Nature Reviews Cardiology, 20(8), 546\u2013559. https:\/\/doi.org\/10.1038\/s41569-023-00845-7","journal-title":"Nature Reviews Cardiology"},{"issue":"10","key":"11030_CR6","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/eurheartj\/ehac818","volume":"44","author":"F Iqbal","year":"2023","unstructured":"Iqbal, F., Schlotter, F., Becker-Greene, D., Lupieri, A., Goettsch, C., Hutcheson, J. D., Rogers, M. A., Itoh, S., Halu, A., Lee, L. H., Blaser, M. C., Mlynarchik, A. K., Hagita, S., Kuraoka, S., Chen, H. Y., Engert, J. C., Passos, L. S. A., Jha, P. K., Osborn, E. A., & Aikawa, E. (2023). Sortilin enhances fibrosis and calcification in aortic valve disease by inducing interstitial cell heterogeneity. European Heart Journal, 44(10), 885\u2013898. https:\/\/doi.org\/10.1093\/eurheartj\/ehac818","journal-title":"European Heart Journal"},{"issue":"30","key":"11030_CR7","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1093\/eurheartj\/ehab316","volume":"42","author":"Y Wang","year":"2021","unstructured":"Wang, Y., Han, D., Zhou, T., Chen, C., Cao, H., Zhang, J. Z., Ma, N., Liu, C., Song, M., Shi, J., Jin, X., Cao, F., & Dong, N. (2021). DUSP26 induces aortic valve calcification by antagonizing MDM2-mediated ubiquitination of DPP4 in human valvular interstitial cells. European Heart Journal, 42(30), 2935\u20132951. https:\/\/doi.org\/10.1093\/eurheartj\/ehab316","journal-title":"European Heart Journal"},{"key":"11030_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109985","volume":"125","author":"Y Huang","year":"2020","unstructured":"Huang, Y., Zhou, X., Liu, M., Zhou, T., Shi, J., Dong, N., & Xu, K. (2020). The natural compound andrographolide inhibits human aortic valve interstitial cell calcification via the NF-kappa B\/Akt\/ERK pathway. Biomedicine & Pharmacotherapy, 125, Article 109985. https:\/\/doi.org\/10.1016\/j.biopha.2020.109985","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"11030_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.123.065143","author":"Z Cai","year":"2024","unstructured":"Cai, Z., Zhu, M., Xu, L., Wang, Y., Xu, Y., Yim, W. Y., Cao, H., Guo, R., Qiu, X., He, X., Shi, J., Qiao, W., & Dong, N. (2024). Directed differentiation of human induced pluripotent stem cells to heart valve cells. Circulation. https:\/\/doi.org\/10.1161\/circulationaha.123.065143","journal-title":"Circulation"},{"issue":"3","key":"11030_CR10","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1021\/acsbiomaterials.8b01280","volume":"5","author":"B Duan","year":"2019","unstructured":"Duan, B., Xu, C., Das, S., Chen, J. M., & Butcher, J. T. (2019). Spatial regulation of valve interstitial cell phenotypes within Three-Dimensional micropatterned hydrogels. ACS Biomaterials Science & Engineering, 5(3), 1416\u20131425. https:\/\/doi.org\/10.1021\/acsbiomaterials.8b01280","journal-title":"ACS Biomaterials Science & Engineering"},{"key":"11030_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.actbio.2021.11.030","volume":"140","author":"K Stadelmann","year":"2022","unstructured":"Stadelmann, K., Weghofer, A., Urbanczyk, M., Maulana, T. I., Loskill, P., Jones, P. D., & Schenke-Layland, K. (2022). Development of a bi-layered cryogenic electrospun polylactic acid scaffold to study calcific aortic valve disease in a 3D co-culture model. Acta Biomaterialia, 140, 364\u2013378. https:\/\/doi.org\/10.1016\/j.actbio.2021.11.030","journal-title":"Acta Biomaterialia"},{"key":"11030_CR12","doi-asserted-by":"publisher","DOI":"10.1088\/1748-605X\/ac9f91","author":"MB Immohr","year":"2022","unstructured":"Immohr, M. B., Dos Santos Adrego, F., Teichert, H. L., Schmidt, V., Sugimura, Y., Bauer, S., Barth, M., Lichtenberg, A., & Akhyari, P. (2022). 3D-bioprinting of aortic valve interstitial cells: Impact of hydrogel and printing parameters on cell viability. Biomedical Materials (Bristol, England). https:\/\/doi.org\/10.1088\/1748-605X\/ac9f91","journal-title":"Biomedical Materials (Bristol, England)"},{"issue":"23","key":"11030_CR13","doi-asserted-by":"publisher","first-page":"e2303972","DOI":"10.1002\/adhm.202303972","volume":"13","author":"KJ De Jesus Morales","year":"2024","unstructured":"De Jesus Morales, K. J., Santosa, U., Brazhkina, O., Rajurkar, P., Jo, H., & Davis, M. E. (2024). A biomimetic leaflet scaffold for aortic valve remodeling. Advanced Healthcare Materials, 13(23), e2303972. https:\/\/doi.org\/10.1002\/adhm.202303972","journal-title":"Advanced Healthcare Materials"},{"issue":"2","key":"11030_CR14","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1016\/j.jtcvs.2019.10.039","volume":"161","author":"T Zhou","year":"2021","unstructured":"Zhou, T., Han, D., Liu, J., Shi, J., Zhu, P., Wang, Y., & Dong, N. (2021). Factors influencing osteogenic differentiation of human aortic valve interstitial cells. The Journal of Thoracic and Cardiovascular Surgery, 161(2), e163\u2013e185. https:\/\/doi.org\/10.1016\/j.jtcvs.2019.10.039","journal-title":"The Journal of Thoracic and Cardiovascular Surgery"},{"issue":"14","key":"11030_CR15","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1161\/CIRCULATIONAHA.121.054744","volume":"144","author":"D Zhou","year":"2021","unstructured":"Zhou, D., Feng, H., Yang, Y., Huang, T., Qiu, P., Zhang, C., Olsen, T. R., Zhang, J., Chen, Y. E., Mizrak, D., & Yang, B. (2021). hiPSC modeling of lineage-specific smooth muscle cell defects caused by TGFBR1A230T variant, and its therapeutic implications for Loeys-Dietz syndrome. Circulation, 144(14), 1145\u20131159. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.054744","journal-title":"Circulation"},{"key":"11030_CR16","doi-asserted-by":"publisher","unstructured":"Strobel, H. A., Calamari, E. L., Alphonse, B., Hookway, T. A., & Rolle, M. W. (2018). Fabrication of custom agarose wells for cell seeding and tissue ring self-assembly using 3D-printed molds. Journal of Visualized Experiments(134). https:\/\/doi.org\/10.3791\/56618","DOI":"10.3791\/56618"},{"issue":"1","key":"11030_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.stemcr.2016.05.004","volume":"7","author":"BC Dash","year":"2016","unstructured":"Dash, B. C., Levi, K., Schwan, J., Luo, J., Bartulos, O., Wu, H., Qiu, C., Yi, T., Ren, Y., Campbell, S., Rolle, M. W., & Qyang, Y. (2016). Tissue-engineered vascular rings from human iPSC-derived smooth muscle cells. Stem Cell Reports, 7(1), 19\u201328. https:\/\/doi.org\/10.1016\/j.stemcr.2016.05.004","journal-title":"Stem Cell Reports"},{"key":"11030_CR18","doi-asserted-by":"publisher","DOI":"10.3791\/3366","volume":"57","author":"TA Gwyther","year":"2011","unstructured":"Gwyther, T. A., Hu, J. Z., Billiar, K. L., & Rolle, M. W. (2011). Directed cellular self-assembly to fabricate cell-derived tissue rings for biomechanical analysis and tissue engineering. Journal of Visualized Experiments, 57, Article e3366. https:\/\/doi.org\/10.3791\/3366","journal-title":"Journal of Visualized Experiments"},{"issue":"3","key":"11030_CR19","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.bbrc.2018.04.141","volume":"500","author":"F Liu","year":"2018","unstructured":"Liu, F., Chu, C., Wei, Q., Shi, J., Li, H., & Dong, N. (2018). Metformin ameliorates TGF-\u03b21-induced osteoblastic differentiation of human aortic valve interstitial cells by inhibiting \u03b2-catenin signaling. Biochemical and Biophysical Research Communications, 500(3), 710\u2013716. https:\/\/doi.org\/10.1016\/j.bbrc.2018.04.141","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"11030_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-021-00416-x","volume":"27","author":"Q En","year":"2021","unstructured":"En, Q., Zeping, H., Yuetang, W., Xu, W., & Wei, W. (2021). Metformin alleviates the calcification of aortic valve interstitial cells through activating the PI3K\/AKT pathway in an AMPK dependent way. Molecular Medicine (Cambridge, Mass.), 27(1), Article 156. https:\/\/doi.org\/10.1186\/s10020-021-00416-x","journal-title":"Molecular Medicine (Cambridge, Mass.)"},{"issue":"1","key":"11030_CR21","doi-asserted-by":"publisher","first-page":"21435","DOI":"10.1038\/s41598-023-47774-6","volume":"13","author":"K Phadwal","year":"2023","unstructured":"Phadwal, K., Tan, X., Koo, E., Zhu, D., & MacRae, V. E. (2023). Metformin ameliorates valve interstitial cell calcification by promoting autophagic flux. Scientific Reports, 13(1), 21435. https:\/\/doi.org\/10.1038\/s41598-023-47774-6","journal-title":"Scientific Reports"},{"key":"11030_CR22","doi-asserted-by":"publisher","first-page":"103215","DOI":"10.1016\/j.redox.2024.103215","volume":"73","author":"C Jiang","year":"2024","unstructured":"Jiang, C., Yao, D., Liu, Z., Zheng, Y., Chen, M., Yim, W. Y., Zheng, Q., Zhang, T., Fan, L., Fan, Z., Geng, B., Tian, R., Zhou, T., Qiao, W., Shi, J., Li, F., Xu, L., Huang, Y., & Dong, N. (2024). FOXO1 regulates RUNX2 ubiquitination through SMURF2 in calcific aortic valve disease. Redox Biology, 73, 103215. https:\/\/doi.org\/10.1016\/j.redox.2024.103215","journal-title":"Redox Biology"},{"key":"11030_CR23","doi-asserted-by":"publisher","unstructured":"Tang, Y., Cheng, J., Huang, C., Qiu, P., Li, J., Chen, Y. E., Mizrak, D., & Yang, B. (2025). TGFBR3 dependent mechanism of TGFB2 in smooth muscle cell differentiation and implications for TGFB2-related aortic aneurysm. Stem Cells Translational Medicine, 14(3). https:\/\/doi.org\/10.1093\/stcltm\/szae101","DOI":"10.1093\/stcltm\/szae101"},{"key":"11030_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413536","author":"R Villa-Bellosta","year":"2021","unstructured":"Villa-Bellosta, R. (2021). Vascular calcification: Key roles of phosphate and pyrophosphate. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms222413536","journal-title":"International Journal of Molecular Sciences"},{"key":"11030_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/biom11060873","author":"X Guo","year":"2021","unstructured":"Guo, X., Li, X., Yang, W., Liao, W., Shen, J. Z., Ai, W., Pan, Q., Sun, Y., Zhang, K., Zhang, R., Qiu, Y., Dai, Q., Zheng, H., & Guo, S. (2021). Metformin targets Foxo1 to control glucose homeostasis. Biomolecules. https:\/\/doi.org\/10.3390\/biom11060873","journal-title":"Biomolecules"},{"key":"11030_CR26","doi-asserted-by":"publisher","first-page":"100342","DOI":"10.1016\/j.mtbio.2022.100342","volume":"16","author":"S Miao","year":"2022","unstructured":"Miao, S., Zhou, J., Liu, B., Lei, X., Wang, T., Hao, X., Cheng, P., Wu, H., Song, Y., Pei, G., & Bi, L. (2022). A 3D bioprinted nano-laponite hydrogel construct promotes osteogenesis by activating PI3K\/AKT signaling pathway. Materials Today Bio, 16, 100342. https:\/\/doi.org\/10.1016\/j.mtbio.2022.100342","journal-title":"Materials Today Bio"},{"issue":"20","key":"11030_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307319","volume":"11","author":"Z Liu","year":"2024","unstructured":"Liu, Z., Wang, K., Jiang, C., Chen, Y., Liu, F., Xie, M., Yim, W. Y., Yao, D., Qian, X., Chen, S., Shi, J., Xu, K., Wang, Y., & Dong, N. (2024). Morusin alleviates aortic valve calcification by inhibiting valve interstitial cell senescence through Ccnd1\/Trim25\/Nrf2 axis. Advanced Science (Weinheim, Baden-Wurttemberg, Germany), 11(20), Article e2307319. https:\/\/doi.org\/10.1002\/advs.202307319","journal-title":"Advanced Science (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"5","key":"11030_CR28","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1183\/09031936.00174914","volume":"45","author":"L Wollin","year":"2015","unstructured":"Wollin, L., Wex, E., Pautsch, A., Schnapp, G., Hostettler, K. E., Stowasser, S., & Kolb, M. (2015). Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis. European Respiratory Journal, 45(5), 1434\u20131445. https:\/\/doi.org\/10.1183\/09031936.00174914","journal-title":"European Respiratory Journal"},{"issue":"5770","key":"11030_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1126\/science.1124287","volume":"312","author":"JP Habashi","year":"2006","unstructured":"Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D., Loeys, B. L., Cooper, T. K., Myers, L., Klein, E. C., Liu, G., Calvi, C., Podowski, M., Neptune, E. R., Halushka, M. K., Bedja, D., Gabrielson, K., Rifkin, D. B., Carta, L., Ramirez, F., Huso, D. L., & Dietz, H. C. (2006). Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science (New York, N.Y.), 312(5770), 117\u2013121.","journal-title":"Science (New York, N.Y.)"},{"issue":"746","key":"11030_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg6298","volume":"16","author":"Y Yang","year":"2024","unstructured":"Yang, Y., Feng, H., Tang, Y., Wang, Z., Qiu, P., Huang, X., Chang, L., Zhang, J., Chen, Y. E., Mizrak, D., & Yang, B. (2024). Bioengineered vascular grafts with a pathogenic TGFBR1 variant model aneurysm formation in vivo and reveal underlying collagen defects. Science Translational Medicine, 16(746), Article eadg6298. https:\/\/doi.org\/10.1126\/scitranslmed.adg6298","journal-title":"Science Translational Medicine"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-11030-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-025-11030-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-11030-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:16:55Z","timestamp":1769750215000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-025-11030-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["11030"],"URL":"https:\/\/doi.org\/10.1007\/s12015-025-11030-3","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were performed according to the protocols approved by the University of Michigan\u2019s Institutional Review Board (HUM00054585 and HUM00052866).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}}]}}